Sodium bicarbonate versus sodium chloride and oral N-acetylcysteine for the prevention of contrast-induced nephropathy in advanced chronic kidney disease

Journal of Interventional Cardiology

Volumn 22, Issue 6, 2009, Pages 556-563

  Shavit, Linda ^a   Korenfeld, Roman ^a   Lifschitz, Meyer ^a   Butnaru, Ady ^a   Slotki, Itzchak ^a  

^a SHAARE ZEDEK MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; BICARBONATE; SODIUM CHLORIDE;

ADULT; AGED; ARTICLE; CHRONIC KIDNEY DISEASE; CONTRAST INDUCED NEPHROPATHY; CREATININE BLOOD LEVEL; DRUG EFFICACY; FEMALE; HEART CATHETERIZATION; HUMAN; HYDRATION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; TREATMENT OUTCOME;

ACETYLCYSTEINE; AGED; CONTRAST MEDIA; CREATINE; DEHYDRATION; FEMALE; FREE RADICAL SCAVENGERS; GLOMERULAR FILTRATION RATE; HEART CATHETERIZATION; HUMANS; KIDNEY DISEASES; KIDNEY FAILURE, CHRONIC; MALE; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; RISK ASSESSMENT; SODIUM BICARBONATE; SODIUM CHLORIDE; STATISTICS AS TOPIC;

EID: 71149088484     PISSN: 08964327     EISSN: 15408183     Source Type: Journal    
DOI: 10.1111/j.1540-8183.2009.00500.x     Document Type: Article

References (23)

1. Shavit L, Lifschitz M, Rosenmann D, et al. Use of N-acetylcysteine prior to cardiac catheterization to prevent acute kidney injury in patients with stage III chronic kidney disease. Harefuah 2007 146 : 655 659, 736.
2. Merten GJ, Burgess WP, Gray Lvet, et al. Prevention of contrast-induced nephropathy with sodium bicarbonate: A randomized controlled trial. JAMA 2004 291 : 2328 2334.
3. From AM, Bartholmai BJ, Williams AW, et al. Sodium bicarbonate is associated with an increased incidence of contrast nephropathy: A retrospective cohort study of 7977 patients at Mayo Clinic. J Am Soc Nephrol 2008 3 : 10 18.
4. Mehran R, Aymong ED, Nikolsky E, et al. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention. J Am Coll Cardiol 2004 44 : 1393 1399.
5. Rihal CS, Textor SC, Grill DE, et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 2002 105 : 2259.
6. Briguori C, Colombo A, Violante A, et al. Standard vs double dose of N-acetylcysteine to prevent contrast agent associated nephrotoxicity. Eur Heart J 2004 25 : 206 211.
7. Detrenis S, Meschi M, Musini S, et al. Lights and shadows on the pathogenesis of contrast-induced nephropathy: State of the art. Nephrol Dial Transplant 2005 20 : 1542.
8. Persson PB, Hansell P, Liss P. Pathophysiology of contrast medium-induced nephropathy. Kidney Int 2005 68 : 14.
9. Heyman SN, Rosenberger C, Rosen S. Regional alterations in renal haemodynamics and oxygenation: A role in contrast medium-induced nephropathy. Nephrol Dial Transplant 2005 20 (Suppl 1. i6.
10. Agmon Y, Peleg H, Greenfield Z, et al. Nitric oxide and prostanoids protect the renal outer medulla from radiocontrast toxicity in the rat. J Clin Invest 1994 94 : 1069.
11. Weisberg LS, Kurnik PB, Kurnik BR. Radiocontrast-induced nephropathy in humans. Role of renal vasoconstriction. Kidney Int 1992 41 : 1408.
12. Cantley LG, Clark BA, et al. Role of endothelin and prostaglandins in radiocontrast-induced renal artery constriction. Kidney Int 1993 44 : 1217.
13. Briguori C, Airoldi F, D'Andrea D, et al. Renal insufficiency following contrast media administration trial (remedial): A randomized comparison of 3 preventive strategies. Circulation 2007 115 : 1211 1217.
14. Recio-Mayoral A, Chaparro M, Prado B, et al. The reno-protective effect of hydration with sodium bicarbonate plus N-acetylcysteine in patients undergoing emergency percutaneous coronary intervention: The RENO Study. J Am Coll Cardiol 2007 49 : 1283 1288. Epub Mar 12, 2007.
15. Ozcan EE, Guneri SA, Kdeniz B, et al. Sodium bicarbonate, N-acetylcysteine, and saline for prevention of radiocontrast-induced nephropathy. A comparison of 3 regimens for protecting contrast-induced nephropathy in patients undergoing coronary procedures. A single-center prospective controlled trial. Am Heart J 2007 154 : 539 544.
16. Aspelin P, Aubry P, Fransson SG, et al. Nephrotoxic effects in high-risk patients undergoing angiography. N Engl J Med 2003 348 : 491.
17. Jo SH, Youn TJ, Koo BK, et al. Renal toxicity evaluation and comparison between visipaque (iodixanol) and hexabrix (ioxaglate) in patientswith renal insufficiency undergoing coronary angiography: The RECOVER study: A randomized controlled trial. J Am Coll Cardiol 2006 48 : 924.
18. Carraro M, Malalan F, Antonione R, et al. Effects of a dimeric vs a monomeric nonionic contrast medium on renal function in patients with mild to moderate renal insufficiency: A double-blind, randomized clinical trial. Eur Radiol 1998 8 : 144.
19. Jakobsen JA, Berg KJ, Kjaersgaard P, et al. Angiography with nonionic X-ray contrast media in severe chronic renal failure: Renal function and contrast retention. Nephron 1996 73 : 549.
20. McCullough PA, Bertrand ME, Brinker JA, et al. A meta-analysis of the renal safety of isosmolar iodixanol compared with low-osmolar contrast media. J Am Coll Cardiol 2006 48 : 692.
21. Brar SS, Shen AY, Jorgensen MB, et al. Sodium bicarbonate vs sodium chloride for the prevention of contrast medium-induced nephropathy in patients undergoing coronary angiography: A randomized trial. JAMA 2008 300 : 1038 1046.
22. Maioli M, Toso A, Leoncini M, et al. Sodium bicarbonate versus saline for the prevention of contrast-induced nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention. J Am Coll Cardiol 2008 52 : 599 604.
23. Meier P, Ko DT, Tamura A, et al. Sodium bicarbonate-based hydration prevents contrast-induced nephropathy: A meta-analysis. BMC Med 2009 7 : 23.